亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jiao Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier]
卷期号:115: 154847-154847 被引量:5
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
二舅司机完成签到,获得积分10
1秒前
Cherry发布了新的文献求助10
9秒前
18秒前
Cherry发布了新的文献求助10
26秒前
LM完成签到,获得积分10
40秒前
汉堡包应助Epiphany采纳,获得10
51秒前
桦奕兮完成签到 ,获得积分10
1分钟前
CWY发布了新的文献求助50
1分钟前
彭于晏应助wdsgkfjhn采纳,获得10
1分钟前
飞天大南瓜完成签到,获得积分10
1分钟前
终归完成签到 ,获得积分10
1分钟前
1分钟前
MchemG应助科研通管家采纳,获得20
1分钟前
MchemG应助科研通管家采纳,获得20
1分钟前
Criminology34应助科研通管家采纳,获得10
1分钟前
辉辉应助科研通管家采纳,获得10
1分钟前
1分钟前
2分钟前
Epiphany发布了新的文献求助10
2分钟前
13633501455完成签到 ,获得积分10
2分钟前
2分钟前
犬来八荒发布了新的文献求助10
2分钟前
2分钟前
Epiphany完成签到,获得积分10
2分钟前
2分钟前
上官若男应助温婉的凝雁采纳,获得10
2分钟前
Alvin完成签到 ,获得积分10
2分钟前
温婉的凝雁完成签到,获得积分10
2分钟前
2分钟前
3分钟前
3分钟前
量子星尘发布了新的文献求助10
3分钟前
王玉发布了新的文献求助10
3分钟前
3分钟前
4分钟前
Cherry发布了新的文献求助10
4分钟前
4分钟前
昌莆完成签到 ,获得积分10
4分钟前
4分钟前
冉亦完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
《药学类医疗服务价格项目立项指南(征求意见稿)》 880
花の香りの秘密―遺伝子情報から機能性まで 800
Stop Talking About Wellbeing: A Pragmatic Approach to Teacher Workload 500
Terminologia Embryologica 500
Silicon in Organic, Organometallic, and Polymer Chemistry 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5617095
求助须知:如何正确求助?哪些是违规求助? 4701461
关于积分的说明 14913699
捐赠科研通 4749054
什么是DOI,文献DOI怎么找? 2549285
邀请新用户注册赠送积分活动 1512345
关于科研通互助平台的介绍 1474091